Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

SELL
$145.48 - $175.02 $65,465 - $78,759
-450 Reduced 14.79%
2,593 $431,000
Q4 2022

Feb 13, 2023

BUY
$131.14 - $157.47 $164,056 - $196,994
1,251 Added 69.81%
3,043 $446,000
Q3 2022

Oct 06, 2022

SELL
$148.29 - $182.55 $33,958 - $41,803
-229 Reduced 11.33%
1,792 $266,000
Q2 2022

Jul 14, 2022

BUY
$155.97 - $200.09 $22,927 - $29,413
147 Added 7.84%
2,021 $347,000
Q1 2022

Apr 28, 2022

BUY
$181.39 - $234.03 $153,455 - $197,989
846 Added 82.3%
1,874 $353,000
Q4 2021

Jan 27, 2022

BUY
$193.69 - $247.03 $199,113 - $253,946
1,028 New
1,028 $251,000
Q4 2018

Feb 14, 2019

SELL
$79.28 - $95.27 $13,160 - $15,814
-166 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$83.5 - $93.23 $13,861 - $15,476
166 New
166 $15,000
Q2 2018

Aug 15, 2018

SELL
$79.9 - $89.2 $13,263 - $14,807
-166 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$71.51 - $84.69 $7,151 - $8,469
100 Added 151.52%
166 $14,000
Q4 2017

Feb 14, 2018

SELL
$63.24 - $72.8 $32,758 - $37,710
-518 Reduced 88.7%
66 $5,000
Q3 2017

Nov 15, 2017

SELL
$59.73 - $65.4 $3,046 - $3,335
-51 Reduced 8.03%
584 $37,000
Q2 2017

Aug 15, 2017

BUY
N/A
635
635 $40,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Krilogy Financial LLC Portfolio

Follow Krilogy Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krilogy Financial LLC with notifications on news.